Literature DB >> 1850043

Identification of a consistent pattern of mutations in neurovirulent variants derived from the sabin vaccine strain of poliovirus type 2.

M Equestre1, D Genovese, F Cavalieri, L Fiore, R Santoro, R Perez Bercoff.   

Abstract

Complete nucleotide sequencing of the RNAs of two unrelated neurovirulent isolates of Sabin-related poliovirus type 2 revealed that two nucleotides and one amino acid (amino acid 143 in the major capsid protein VP1) consistently departed from the sequences of the nonneurovirulent poliovirus type 2 712 and Sabin vaccine strains. This pattern of mutation appeared to be a feature common to all neurovirulent variants of poliovirus type 2.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1850043      PMCID： PMC240633     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  27 in total

1.  Intratypic serodifferentiation of poliomyelitis virus strains by strain-specific antisera.

Authors:  A L van Wezel; A G Hazendonk
Journal:  Intervirology       Date:  1979       Impact factor: 1.763

2.  Three-dimensional structure of poliovirus at 2.9 A resolution.

Authors:  J M Hogle; M Chow; D J Filman
Journal:  Science       Date:  1985-09-27       Impact factor: 47.728

3.  Lyophilized combination pools of enterovirus equine antisera: preparation and test procedures for the identification of field strains of 42 enteroviruses.

Authors:  J L Melnick; V Rennick; B Hampil; N J Schmidt; H H Ho
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

4.  The effect of sequences in the 5' non-coding region on the replication of polioviruses in the human gut.

Authors:  P D Minor; G Dunn
Journal:  J Gen Virol       Date:  1988-05       Impact factor: 3.891

5.  A comprehensive set of sequence analysis programs for the VAX.

Authors:  J Devereux; P Haeberli; O Smithies
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

6.  The carrier state in muscular dystrophy of the Duchenne type.

Authors:  A T Milhorat; L Goldstone
Journal:  JAMA       Date:  1965-10-11       Impact factor: 56.272

7.  Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome.

Authors:  D M Evans; G Dunn; P D Minor; G C Schild; A J Cann; G Stanway; J W Almond; K Currey; J V Maizel
Journal:  Nature       Date:  1985 Apr 11-17       Impact factor: 49.962

8.  Mapping of sequences required for mouse neurovirulence of poliovirus type 2 Lansing.

Authors:  N La Monica; C Meriam; V R Racaniello
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

9.  Paralytic poliomyelitis in Italy (1981-85).

Authors:  F Novello; F Lombardi; C Amato; R Santoro; L Fiore; M E Grandolfo; P Pasquini
Journal:  Eur J Epidemiol       Date:  1987-03       Impact factor: 8.082

10.  Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA.

Authors:  J Pelletier; N Sonenberg
Journal:  Nature       Date:  1988-07-28       Impact factor: 49.962
View more
  9 in total

1.  Correlation of mutations and recombination with growth kinetics of poliovirus vaccine strains.

Authors:  V Pliaka; Z Kyriakopoulou; D Tsakogiannis; I G A Ruether; C Gartzonika; S Levidiotou-Stefanou; A Krikelis; P Markoulatos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-09-05       Impact factor: 3.267

2.  Impact of exogenous sequences on the characteristics of an epidemic type 2 recombinant vaccine-derived poliovirus.

Authors:  Franck B Riquet; Claire Blanchard; Sophie Jegouic; Jean Balanant; Sophie Guillot; Marie-Anne Vibet; Mala Rakoto-Andrianarivelo; Francis Delpeyroux
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

3.  Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs).

Authors:  Radboud J Duintjer Tebbens; Mark A Pallansch; Jong-Hoon Kim; Cara C Burns; Olen M Kew; M Steven Oberste; Ousmane M Diop; Steven G F Wassilak; Stephen L Cochi; Kimberly M Thompson
Journal:  Risk Anal       Date:  2013-03-07       Impact factor: 4.000

4.  Mapping of mutations contributing to the temperature sensitivity of the Sabin 1 vaccine strain of poliovirus.

Authors:  M M Georgescu; M Tardy-Panit; S Guillot; R Crainic; F Delpeyroux
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

5.  Genomic analysis of recombinant sabin clinical isolates.

Authors:  Eleni Paximadi; Ioannis Karakasiliotis; Zissis Mamuris; Constantinos Stathopoulos; Vassilis Krikelis; Panayotis Markoulatos
Journal:  Virus Genes       Date:  2006-04       Impact factor: 2.332

6.  Poliovirus Sabin type 1 neutralization epitopes recognized by immunoglobulin A monoclonal antibodies.

Authors:  L Fiore; B Ridolfi; D Genovese; G Buttinelli; S Lucioli; A Lahm; F M Ruggeri
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

7.  Multiple viral determinants mediate myopathogenicity in coxsackievirus B1-induced chronic inflammatory myopathy.

Authors:  Patricia E Tam; Melissa L Weber-Sanders; Ronald P Messner
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

8.  S2M: A Stochastic Simulation Model of Poliovirus Genetic State Transition.

Authors:  Carol L Ecale Zhou
Journal:  Bioinform Biol Insights       Date:  2016-06-27

9.  Molecular and Phenotypic Characterization of a Highly Evolved Type 2 Vaccine-Derived Poliovirus Isolated from Seawater in Brazil, 2014.

Authors:  Klécia Marília S de Melo Cassemiro; Fernanda M Burlandy; Mikaela R F Barbosa; Qi Chen; Jaume Jorba; Elayse M Hachich; Maria I Z Sato; Cara C Burns; Edson E da Silva
Journal:  PLoS One       Date:  2016-03-28       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.